Ironwood Pharmaceuticals (irwd 0.75 06/15/24)
13F holders, Q1 2024 (March 31)2holders
$0.99avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Ironwood Pharmaceuticals (irwd 0.75 06/15/24) in their 13F filings. The largest holders were Arkadios Wealth Advisors ($11K) and Northwestern Mutual Wealth Management Co. ($6K).
- Company
- Ironwood Pharmaceuticals (irwd 0.75 06/15/24)
- CUSIP
- 46333XAF5
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $3.4M |
Ownership 2 holders
| Arkadios Wealth Advisors | 0.00% | No change | 11,000 | $11K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 6,000 | $6K |
"% of holder's portfolio" is IRONWOOD PHARMACEUTICALS (IRWD 0.75 06/15/24)'s weight in each manager's 13F, not the share of Ironwood Pharmaceuticals (irwd 0.75 06/15/24) the manager owns.